Periventricular venous density in multiple sclerosis is inversely associated with T2 lesion count: a 7 Tesla MRI study

Background: Damage to venules in multiple sclerosis was first described decades ago. Today, ultrahigh magnetic field strength T2*-weighted magnetic resonance imaging (MRI) techniques depict very small cerebral veins in vivo with great anatomical detail. Objective: We aimed to investigate alterations of periventricular small blood vessel appearance in relation to T2 lesion count and distribution in multiple sclerosis and clinically isolated syndrome in comparison with healthy control subjects at 7 Tesla MRI. Methods: We investigated 38 patients (including 16 with early multiple sclerosis and seven with clinically isolated syndrome) and 22 matched healthy controls at 7 Tesla. The protocol included T2*-weighted Fast Low Angle Shot, and T2-weighted Turbo Inversion Recovery Magnitude sequences. We quantified periventricular venous density by a novel region-of-interest-based algorithm, expressing the ratio of ‘veins per region-of-interest’ as well as of ‘periventricular vascular area’. Results: Our study revealed significantly decreased venous density in multiple sclerosis patients compared with healthy controls. Venous alterations were already detectable in clinically isolated syndrome and early multiple sclerosis, although to a smaller extent. Venous density correlated inversely with periventricular and whole-brain T2 lesion count. Furthermore, we found no indication for cerebral venous congestion in multiple sclerosis. Conclusion: High spatially resolving anatomical T2*-weighted MRI revealed vascular alterations in early stages of multiple sclerosis, presumably as a part of widespread haemodynamic and metabolic alterations.

[1]  C. Pfueller,et al.  Venous drainage in multiple sclerosis , 2011, Neurology.

[2]  H. Koprowski,et al.  Ultrastructural studies of perivascular cuffing cells in multiple sclerosis brain. , 1975, The American journal of pathology.

[3]  J. Dawson,et al.  The Histology of Disseminated Sclerosis , 1916, Edinburgh Medical Journal.

[4]  F. Salvi,et al.  Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report , 2011, BMC medicine.

[5]  W R Kinkel,et al.  High‐Resolution Fluorodeoxyglucose Positron Emission Tomography Shows Both Global and Regional Cerebral Hypometabolism in Multiple Sclerosis , 1998, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[6]  F Barkhof,et al.  MR venography of multiple sclerosis. , 2000, AJNR. American journal of neuroradiology.

[7]  Glyn Johnson,et al.  Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. , 2005, AJNR. American journal of neuroradiology.

[8]  G. Johnson,et al.  Microvascular Abnormality in Relapsing-remitting Multiple Sclerosis: Perfusion Mr Imaging Findings in Normal-appearing White Matter , 2003 .

[9]  A. Wakefield,et al.  Immunohistochemical study of vascular injury in acute multiple sclerosis. , 1994, Journal of clinical pathology.

[10]  M. Filippi,et al.  Functional magnetic resonance imaging correlates of cognitive performance in patients with a clinically isolated syndrome suggestive of multiple sclerosis at presentation: an activation and connectivity study , 2012, Multiple sclerosis.

[11]  C. Pfueller,et al.  Multiple sclerosis lesions and irreversible brain tissue damage: a comparative ultrahigh-field strength magnetic resonance imaging study. , 2012, Archives of neurology.

[12]  Jullie W Pan,et al.  DEMONSTRATING THE PERIVASCULAR DISTRIBUTION OF MS LESIONS IN VIVO WITH 7-TESLA MRI , 2008, Neurology.

[13]  P S Morgan,et al.  Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions , 2011, Neurology.

[14]  R. Grossman,et al.  Prominent perivenular spaces in multiple sclerosis as a sign of perivascular inflammation in primary demyelination. , 2005, AJNR. American journal of neuroradiology.

[15]  F. Kantarcı,et al.  Prevalence, sensitivity, and specificity of chronic cerebrospinal venous insufficiency in MS , 2011, Neurology.

[16]  C. W. Adams,et al.  Perivascular iron deposition and other vascular damage in multiple sclerosis. , 1988, Journal of neurology, neurosurgery, and psychiatry.

[17]  Robert Zivadinov,et al.  Decreased brain venous vasculature visibility on susceptibility-weighted imaging venography in patients with multiple sclerosis is related to chronic cerebrospinal venous insufficiency , 2011, BMC neurology.

[18]  M Rovaris,et al.  Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. , 2003, Brain : a journal of neurology.

[19]  M. Blinkenberg,et al.  Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS , 2000, Neurology.

[20]  Nikos Evangelou,et al.  A Comparison of 3T and 7T in the Detection of Small Parenchymal Veins Within MS Lesions , 2009, Investigative radiology.

[21]  M. Schlamann,et al.  First Clinical Study on Ultra-High-Field MR Imaging in Patients with Multiple Sclerosis: Comparison of 1.5T and 7T , 2009, American Journal of Neuroradiology.

[22]  J. Dawson,et al.  XVIII.–The Histology of Disseminated Sclerosis , 1916, Transactions of the Royal Society of Edinburgh.

[23]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[24]  G. Johnson,et al.  White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis , 2009, Journal of the Neurological Sciences.

[25]  M. Cambron,et al.  Vascular aspects of multiple sclerosis , 2011, The Lancet Neurology.

[26]  E. Ringelstein,et al.  Lesion morphology at 7 Tesla MRI differentiates Susac syndrome from multiple sclerosis , 2012, Multiple sclerosis.

[27]  G. Comi,et al.  Axonal injury in early multiple sclerosis is irreversible and independent of the short-term disease evolution , 2005, Neurology.

[28]  E Mark Haacke,et al.  Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility‐weighted imaging at 3.0 Tesla , 2009, Journal of magnetic resonance imaging : JMRI.

[29]  C. Pfueller,et al.  Distinct lesion morphology at 7-T MRI differentiates neuromyelitis optica from multiple sclerosis , 2012, Neurology.

[30]  Yulin Ge,et al.  Seven-Tesla magnetic resonance imaging: new vision of microvascular abnormalities in multiple sclerosis. , 2008, Archives of neurology.

[31]  Glyn Johnson,et al.  Pattern of hemodynamic impairment in multiple sclerosis: Dynamic susceptibility contrast perfusion MR imaging at 3.0 T , 2006, NeuroImage.

[32]  Frauke Zipp,et al.  Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. , 2004, Brain : a journal of neurology.

[33]  J. Ranjeva,et al.  Relationships between gray matter metabolic abnormalities and white matter inflammation in patients at the very early stage of MS , 2007, Journal of Neurology.

[34]  R. Poston,et al.  Inflammatory vasculitis in multiple sclerosis , 1985, Journal of the Neurological Sciences.

[35]  H. Hartung,et al.  Intracranial venous pressure is normal in patients with multiple sclerosis , 2011, Multiple sclerosis.

[36]  A. Compston,et al.  Multiple sclerosis. , 2002, Lancet.

[37]  F. Paul,et al.  Cerebral blood perfusion changes in multiple sclerosis , 2007, Journal of the Neurological Sciences.

[38]  M. Battaglini,et al.  Pronounced focal and diffuse brain damage predicts short-term disease evolution in patients with clinically isolated syndrome suggestive of multiple sclerosis , 2011, Multiple sclerosis.

[39]  F. Paul,et al.  Perivascular spaces--MRI marker of inflammatory activity in the brain? , 2008, Brain : a journal of neurology.

[40]  David W. Holman,et al.  The blood-brain barrier, chemokines and multiple sclerosis. , 2011, Biochimica et biophysica acta.

[41]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.